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Unlike other weighted capitation schemes used in Irish health service financing and in health 
systems internationally, the GMS capitation payments scheme for General Practitioners lacks 
transparency in both the data used and the model employed. In this study, evidence-based 
weights were generated from four difference sources of utilisation data. These were 
compared to current payment weights. Evidence-based weights indicated that over 70s had 
higher payments per consultation than other groups. Considerable intra-age band differences 
in capitation payment were detected, suggesting that current age bands should be narrowed. 
The implications for the efficiency and equity of general practice in Ireland are discussed. 
  
Introduction 
In 2012, the Irish Department of Health proposed that General Practitioner (GP) care would 
be free at the point of contact and a primary care-focused chronic disease management 
programme would be introduced. The GP contract would be renegotiated and a transparent 
and objective formula for resource allocation would be developed [1]. Since 1989, almost all 
GPs have received a capitation payment for their General Medical Services (GMS) patients. 
Up until 2010, the capitation formula was based on patient age, gender and distance to the 
GP’s principal surgery. Since then, only age and gender have been used. This study examines 
the transparency and empirical basis of the weighted capitation formula used for GMS 
payments to GPs. 
Weighted capitation attempts to compensate providers or insurers for differences in the needs 
profile of their patients. A number of measures of health need can be considered, including 
age, gender and morbidity. Internationally, many health care systems use weighted capitation 
mechanisms for payment in general practice. These range in sophistication from models that 
account for health need using an age weighting only - Czech Republic, Estonia, Latvia and 
Slovenia for instance[2] – to ones that include characteristics of the patient’s area of 
residence – Spain[3] and the Netherlands[4]. The UK model is the most sophisticated in 
Europe. It uses multivariate regression techniques to generate patient weighting based on age, 
gender, additional health needs, local labour costs, rurality, patient list turnover and living in 
a nursing/residential home[5]. Of these, the inclusion of additional health needs, as measured 
by chronic illness and area-level mortality, is the most important for predicting patient costs. 
Additional health needs can be measured in a number of ways. In Ontario they are measured 
through previous use of inpatient and ambulatory health services[6]. Measures of chronic 
illness generated from prescription medicine claims have been used for weighted capitation 
models in the US and the Netherlands[7, 8], while they were used for the GMS prescribed 
medicines budget in Ireland[9]. 
Aside from GP capitation payments, the Irish health care system has a number of examples of 
weighted capitation financing, including the national casemix programme for public hospital 
services; the Risk Equalisation Scheme in private health insurance and the now defunct 
Indicative Drug Target Scheme. In the national casemix programme, hospital patients are 
coded into Diagnostic-Related Groups (DRGs) which are used to alter hospital budgets to 
account for variations in case complexity. In the Risk Equalisation Scheme, health insurance 
companies are compensated or penalised based on the age and gender profile of their 
claimants.  The Indicative Drug Target Scheme used age bands to generate indicative drug 
expenditure targets for each GP’s GMS panel. In these three cases the data sources used for 
the model are transparent. This is not the case for the GP capitation model. Therefore it is not 
possible to explain the payment differentials found in the GP capitation scheme with 
currently available information. 
This study generated capitation weights based on the association of age and gender with 
consultations and compared them to current capitation weights.  As such it assumed that 
consultation time and associated administration is equal across age/gender groups and 
therefore each consultation should be compensated equally. This may not be the case for 
certain age/gender groups such as those with a higher proportion of multi-morbid patients, 
who tend to be older [10] or women of childbearing age. There is Irish evidence to suggest 
the elderly have more ailments addressed per consultation [11] and UK evidence that finds 
that this leads to longer consultation times [12]. Nevertheless alternatives such as time per 
consultation can also be problematic (personal communication, CompleteGP) and utilisation 
is the most commonly used measure of resource use in weighted capitation internationally. In 
addition, in the private market for GP consultations in Ireland all age/gender groups pay the 
same basic fee, although particular age/gender groups – typically sicker ones including the 




There is no routinely generated dataset that links GP utilisation to GMS patient 
characteristics in Ireland. Two approaches were examined. The first is the use of an 
administrative database which could contain sampling bias; the second is the use of several 
patient self-reported surveys, which could contain recall bias. In order to compare utilisation 
across the chosen datasets, over 18s only were examined. 
First, Behan et al. (2013)[13] (hereafter Behan13) published age-related utilisation rates for 
GMS recipients in a number of GP practices in Ireland using data from an administrative 
database. Second, the Quarterly National Household Survey (QNHS)[14], Healthy Ireland 
[15] and The Irish Longitudinal Study on Aging (TILDA)[16, 17] were used. The microdata 
for Healthy Ireland and TILDA were accessed through the Irish Social Sciences Data 
Archive[18]. 
The Behan13 data were extracted from the GP administrative records of six practices in 
2012/13. It covered 27,080 patients of whom 42% were GMS-entitled. The over 18 
population was 20,706 so the over 18 GMS population was estimated at approximately 8,697 
(20,706*0.42). It appears to be reasonably representative of national demographics, although 
it may underrepresent remote rural and inner-city populations, or particular socio-economic 
groups. The latter was found to be the case for sentinel practices in England and Wales[19]. 
In addition, it may be unrepresentative of General Practice in Ireland, with respect to age and 
gender distribution of the GPs and other clinical and support staff, or with respect to quality 
standards. Also, home visits and telephone consultations were collected in one practice only 
and extrapolated to all six. 
 
The principal focus of the QNHS is to collect data on labour market outcomes and related 
socio-economic and demographic factors for the population aged over 18. Modules in areas 
of special interest are conducted quarterly. Health modules were conducted in Quarter 3 of 
2001, 2007 and 2010.  As it is the most recent, this study used the 2010 data. It was 
nationally representative with a sample size of 6,232 GMS recipients. 
 
Healthy Ireland is a nationally representative annual survey of the population over 15, run by 
the Department of Health and Ispos/MRBI and first conducted in 2014/15[15].  It has a GMS 
sample of 3,444. The Irish Longitudinal Study on Ageing or TILDA[16] collects data on 
various aspects of the lives of people aged 50 and over, including GP utilisation. It is 
conducted every two years. This study used Wave 1 (hereafter TILDAw1), as it allows GP 
utilisation to be calculated.  Wave 1 was conducted from 2009 to 2011 and had a sample size 
of 8,504, of whom 4,014 were GMS-entitled and aged 50 or over.  
 
There are a number of other self-reported surveys that were excluded. The Irish Health 
Survey[20] reports proportion attending GP only, not frequency of attendance. The Growing 
Up in Ireland[21] study does not include over 18s and the Household Budget Survey[22] is 
not conducted at individual level and has only 3 age groups comparable to those in this study. 
 
The definition of consultation was slightly different in the datasets used. Behan13, the QNHS 
2010:Q3 (hereafter QNHS10) and Healthy Ireland used the same definition, which included 
consultations in clinics, home visits and by phone. However, in Behan13 and the QNHS10, 
some types of telephone consultations such as discussion of test results were excluded. 
TILDAw1 excluded telephone consultations[23]. 
 
For a relatively infrequent activity such as GP utilisation, retrospective, self-reported surveys 
must choose a recall window that is wide enough to ensure completeness (e.g. that there are 
not a disproportionate number of zeroes) but narrow enough to ensure that responses are 
accurate. There is no consensus in the literature on optimal recall period, but it appears to 
depend on the objective of the survey, and the frequency and saliency of the encounters [24-
26]. Retrospective recall has been associated with underreporting, especially of community-
based health care services [24, 26]. QNHS10 and TILDAw1 chose a recall period of 12 
months and Healthy Ireland chose 4 weeks. The European Health Interview Survey[27], 
which covers all EU countries, Iceland and Norway, and of which the Irish Health Survey[20] 
is a component part, uses a 4 week recall period. In other Irish surveys of GP utilisation, a 2 
week period was used in the QNHS in 2001[28]; a 4 week period was used in the Household 




Table 1 presents the GP consultations by age and gender. 
Table 1 GP consultations by Age/Gender group and Survey 
Age 
Group 
Behan13 QNHS10 Healthy Ireland TILDAw1 
Male Female Male Female Male Female Male Female 
18-24 4.1 3.8 2.1 5.1 
  25-34 5.2 4.9 3.3 
 
5.8 
   35-44 5.8 4.7 
  45-54 6.5 5.6 6.1 
 
6.6 
   55-64 7.5 6 5.4 5.6 





70+ 9.8 5.6 5.3 5.3 
Sources: Behan et al., 2013 [13];CSO, 2011[14]; Irish Social Science Data Archive[18]. 
 
The first two datasets, Behan13 and QNHS10, did not disaggregate by gender. Therefore the 
same utilisation was applied to both genders. Behan13 rose steadily from 4.1 consultations 
per annum for 18-24 year olds to 9.8 per annum for over 70s. The annual consultation rate in 
the QNHS10 was lower than Behan13 and peaks at 6 consultations per annum for 55-64 year 
olds. 
One of the advantages of including Healthy Ireland and TILDAw1 data is that they 
disaggregate by gender. Healthy Ireland used wider age groups (18-24, 25-44, 45-64 and 
65+). The only comparable age/gender groups from TILDAw1 were 55–64 and above. There 
was a strong age gradient in Healthy Ireland, with male consultations rising from 2.1 for 
males aged 18-24 to 8.4 for males aged over 65 and female consultations rising 5.1 for 
females aged 18-24 to 8.5 for females aged over 65. TILDAw1 did not exhibit an age 
gradient, with peaks in age group 65-69 for males, and in age group 55-64 for females. 
There were considerable differences in utilisation across datasets. In Healthy Ireland, the 
simple average of males and females aged 18-24 was 3.6 in Healthy Ireland, which was 
similar to QNHS10 and slightly lower than Behan13. For those aged 25-44 it was 4.5 which 
again was similar to QNHS10 and lower than Behan13. For age group 45-64, it was 6.4, 
which was closer to Behan13 than QNHS10 or TILDAw1. For the over 65 age group 65 it 
was 8.4, which was closer to Behan13 than either QNHS10 or TILDAw1. 
A notable feature of the Healthy Ireland data was the considerable gender difference in 
utilisation, where female utilisation exceeded that of males, although the gap narrowed with 
age. 
Across all 4 datasets and taking the simple average of males and females in Healthy Ireland, 
Behan13 recorded the highest levels of utilisation for all age groups. For the datasets reliant 
on self-reported data, QNHS10 had higher rates than Healthy Ireland for adults under 45 and 
Healthy Ireland had higher rates for those 45 and over. TILDAw1 had the lowest rates of 




Table 2 presents capitation payments for each age/gender group by survey. 




Capitation  Behan Healthy Ireland QNHS10 TILDAw1 
Male Female Male Female Male Female Male Female Male Female 
18-24 0.50 0.82 0.55 0.34 0.83 0.63     
25-34 0.50 0.82 0.69 0.54 0.95 
0.82     
35-44 0.50 0.82 0.77 0.78     
45-54 1.00 1.10 0.87 1.00 1.08 
0.93     
55-64 1.00 1.10 1.00 1.00 1.00 1.04 
65-69 1.05 1.17 1.17 1.37 1.39 
0.87 1.02 0.91 
70+ 2.46 2.46 1.31 0.93 0.98 0.97 
Sources: Primary Care Reimbursement Service, 2013[29]; Behan et al., 2013 [13];CSO, 
2011[14];Irish Social Sciences Data Archive[18]. 
 
All data are indexed to males 55-64=1.00 as this is the first comparable age/gender group for 
which we have TILDAw1 data. The most notable feature of the capitation payments is the 
146% jump in the index for those aged over 70 compared with the base group, which is 
almost 5 times the payment to males aged 18-44. Capitation payments based on Behan would 
range from 55% to 131% of the base group, rising consistently with age. Based on Healthy 
Ireland, payments would vary from 34% to 137% of the base group for males, again rising 
consistently with age. For females, the age gradient would be flatter, varying from a payment 
of 83% of the base group for the youngest group to 39% greater than the base group for the 
over 70s. This pattern is reasonably similar to current capitation payments for females up to 
the age of 65. Payments based on QNHS10 would peak at the base group and would be 63% 
of base group payment for the youngest age group, 93% thereof for over 70s. Based on 
TILDAw1, payments would vary very little for males, somewhat more for females. 
 
There are also notable intra-band differences in utilisation. Current payments do not changes 
from ages 18-44, or from 45-64. However, payments to those aged 18-44 would vary from 
between 0.55 to 0.77 according to Behan13; 0.63 to 0.78 according to QNHS10 and 0.34 to 
0.54 for males or 0.83 to 0.95 for females according to Healthy Ireland. There would also be 
intra-band differences for those aged 45-64, again varying by data source. 
 
Discussion 
The source of the dataset used to calculate current GMS capitation payments is not publicly 
known. This study sought to highlight this lack of transparency by deriving age/gender-
related capitation weights from published sources and comparing these with the current 
age/gender-related capitation weights. Significant differences emerged. In particular, 
empirically-derived weights indicated that the over 70s had a much higher ratio of capitation 
payment to utilisation than other age groups. 
 
Utilisation varied considerably within the current capitation age groups. Narrowing the age 
groups for GP capitation payment to, perhaps, 5 year bands (as is the typical age grouping for 
weighted capitation models) may be worth considering. 
 
Patients over 70 carried a particularly high capitation payment relative to utilisation. The 
weekly income limit for entitlement to GMS services for a single person over 70 was €500 in 
2015 whereas it was €184 for a single person under 65 (by way of comparison Jobseekers 
Allowance was €188 and median income was €367 in 2013[29]). As such, relatively wealthy 
over 70s qualify as against relatively poor under 70s. Given the long established link between 
health and socio-economic deprivation, a GP serving a relatively wealthy population of over 
70s is likely to be better off than their counterpart serving a relatively deprived population of 
over 70s, and probably a good degree better off than their counterpart serving a GMS 
population of under 70s1. This is compounded by the fact that premature mortality is so much 
                                                 
1 Although beyond the scope of this study due to data limitations, under 6s, who are universally entitled to 
visit GPs for free (at point of contact) since 2015, received a capitation payment of €125 per annum. Before 
higher in deprived populations in Ireland[30, 31] such that GPs serving such populations do 
not benefit from the higher payments to over 70s for as long as their counterparts serving 
richer over 70s. Thus an inequity may arise, which would undermine government policy on 
health service development[1, 32]. 
The emergence of the significantly higher payments to over 70s can be traced to the 
significant increase in the income thresholds relating to that group in 2001 [33] which 
expanded the numbers eligible for GMS to approximately 95% of all over 70s. As a 
consequence of this expansion in eligible numbers, a new capitation rate for those over 70s 
who were eligible for GMS services for the first time was agreed. This continued until 2009, 
when one payment was made for all over 70s. In 2015, a new capitation rate for under 6s was 
agreed with GPs for the expansion of the Doctor Visit card to all in that age group. These ad 
hoc changes to capitation rates may not reflect actual relativities in utilisation rates, 
suggesting that a comprehensive, evidence-based review of the GMS capitation model is 
warranted. 
The study found material differences in reported utilisation in the self-reported surveys, 
depending on the recall period.  Meanwhile, Behan13 does not suffer from recall bias but 
may suffer from sampling bias. Weighted-capitation models used in other health systems use 
much larger, and in some cases population-wide, administrative data,[5, 7, 8] which 
overcomes any sampling bias. 
The ideal weighted capitation model would perfectly predict patient expenditure and base 
capitation on that prediction. As described above, the inclusion of a robust measure of 
additional health needs, markedly improves predictability[5,8]. Many fall short of the ideal 
because data on each need variable must be available for all recipients of the service. Age and 
gender are the only variables available universally in many instances. An Irish study[9] used 
                                                                                                                                                        
this change, the drop in capitation payment for those who remain on the GMS scheme at age 6 was €30.17, a 
41% fall. Since 2015, the fall is at least €81.47, a 65% fall. 
information from prescription medicine claims to generate measures of chronic illness for all 
GMS recipients in a weighted capitation model that was developed for the Indicative Drug 
Target Scheme. The predictive power of the model was over three times greater than an age-
gender based model. Should GP utilisation data become available routinely, a similar 
approach could be adopted for the GP capitation scheme in Ireland, enhancing transparency 
and improving the equity and efficiency in use of health care resources.  
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